Trademark: 97569422
Word
KAVCAPA
Status
Pending
Status Code
686
Status Date
Tuesday, March 12, 2024
Serial Number
97569422
Mark Type
4000
Filing Date
Monday, August 29, 2022
Published for Opposition
Tuesday, March 12, 2024

Trademark Owner History
AstraZeneca AB - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

Trademark Events
Mar 12, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 12, 2024
Published For Opposition
Feb 21, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2024
Notification Of Notice Of Publication E-Mailed
Feb 8, 2024
Electronic Record Review Complete
Feb 2, 2024
On Hold - Electronic Record Review Required
Jan 26, 2024
Approved For Pub - Principal Register
Jan 24, 2024
Teas/Email Correspondence Entered
Jan 24, 2024
Correspondence Received In Law Office
Jan 24, 2024
Assigned To Lie
Sep 5, 2023
Teas Response To Office Action Received
May 23, 2023
Application Extension Granted/Receipt Provided
May 23, 2023
Application Extension To Response Period - Received
Mar 10, 2023
Notification Of Non-Final Action E-Mailed
Mar 10, 2023
Non-Final Action E-Mailed
Mar 10, 2023
Non-Final Action Written
Mar 3, 2023
Assigned To Examiner
Sep 16, 2022
New Application Office Supplied Data Entered
Sep 1, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24